
HAYSMED
Dr. Byungsoo Ko, Cardiologist and Director of the Cardiovascular Cathertization Laboratory at HaysMed, part of The University of Kansas Health System, recently presented at the C3 (Complex Cardiovascular Catheter Therapeutics: Advanced Endovascular and Coronary Intervention Global Summit) international conference. The conference was held in Orlando, Florida.
The C3 Conference is specifically designed for physicians who specialize in interventional cardiology, vascular surgery, and interventional radiology, as well as fellows, residents, and other healthcare professionals interested in atherosclerotic cardiovascular disease. Their mission is to deliver educational innovation through a global exchange of scientific research, new techniques, and technologies to improve patient care and utilize best practices to improve lives of countless individuals across the world.
Dr. Ko presented on Impella Supported Left Main Intervention in a Patient with STEMI Complicated by Cardiogenic Shock.
He also was on a panel for the International Joint Session with Korean Complex Cardiovascular Invention (CCI) Group Complex Endovascular and Structural Heart Disease Intervention.